C-Type Lectin-Like Molecule-1 as a Biomarker for Diagnosis and Prognosis in Acute Myeloid Leukemia: A Preliminary Study

C-Type Lectin-Like Molecule-1 as a Biomarker for Diagnosis and Prognosis in Acute Myeloid Leukemia: A Preliminary Study

Objective. AML is a heterogeneous disease both in genomic and proteomic backgrounds, and variable outcomes may appear in the same cytogenetic risk group. Therefore, it is still necessary to identify new antigens that contribute to diagnostic information and to refine the current risk stratification....

Full description

Bibliographic Details
Main Authors: Jinghua Wang, Weida Wang, Hao Chen, Wenmin Li, Tian Huang, Weiya Zhang, Wei Ling, Peilong Lai, Yulian Wang, Suxia Geng, Minming Li, Xin Du, Jianyu Weng
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2021/6643948

Similar Items

Similar Items